Alzamend Neuro, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted from 2021 to 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Alzamend Neuro, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2021 to 2023.
  • Alzamend Neuro, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending October 31, 2024 was 3.53M shares, a 438% increase year-over-year.
  • Alzamend Neuro, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 677K shares, a 4.07% increase from 2022.
  • Alzamend Neuro, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 650K shares, a 99.3% decline from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 677K +26.4K +4.07% May 1, 2023 Apr 30, 2024 10-K 2024-07-30
2022 650K -88.4M -99.3% May 1, 2022 Apr 30, 2023 10-K 2024-07-30
2021 89.1M May 1, 2021 Apr 30, 2022 10-K 2023-07-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.